GGrantIndex
← Search

Leadership, Planning and Evaluation

$504,600P30FY2024CANIH

University Of Chicago, Chicago IL

Investigators

Linked publications, trials & patents

Paper 39661064Paper 39579248Paper 39438113Paper 39374047Paper 39270007Paper 39141403Paper 39114540Paper 39108474Paper 39071306Paper 39069988Paper 38883758Paper 38881356Paper 38849889Paper 38810242Paper 38771643Paper 38752924Paper 38735044Paper 38716867Paper 38691450Paper 38632339Paper 38561491Paper 38548994Paper 38536082Paper 38533736Paper 38496521Paper 38427437Paper 38421866Paper 38381713Paper 38294692Paper 38294689Paper 38293065Paper 38219706Paper 38213818Paper 38190286Paper 38186960Paper 38175791Paper 38155245Trial NCT02573363Trial NCT02573220Trial NCT02542202Trial NCT02540876Trial NCT02485535Trial NCT02420210Trial NCT02399371Trial NCT02389517Trial NCT02366819Trial NCT02333188Trial NCT02333162Trial NCT02275533Trial NCT02258659Trial NCT02213913Trial NCT02199665Trial NCT02122172Trial NCT02046421Trial NCT02012296Trial NCT01949740Trial NCT01861301Trial NCT01696955Trial NCT01576172Trial NCT01307618Trial NCT01281176Trial NCT01278615Trial NCT01267266Trial NCT01256385Trial NCT01208051Trial NCT01174264Trial NCT01122888Trial NCT01076543Trial NCT01064622Trial NCT00859937Trial NCT00720174Trial NCT00504153Trial NCT00436579Trial NCT00387335Trial NCT00381641Trial NCT00376688Trial NCT00369551Trial NCT00351975Trial NCT00303862Trial NCT00290472Trial NCT00265798Trial NCT00126542Trial NCT00095784Trial NCT00091026Trial NCT00087373Trial NCT00062075Trial NCT00058019Trial NCT00055913Trial NCT00039416Trial NCT00027703Trial NCT00023946Patent 7192711Patent 6870037Patent 6482934Patent 6387619Patent 6043216Patent 5916752Patent 5786344Patent 5698686Patent 5618917

Abstract

PROJECT SUMMARY/ABSTRACT - LEADERSHIP, PLANNING AND EVALUATION (LPE) The Leadership, Planning and Evaluation component of the Cancer Center Support Grant (CCSG) develops and implements a vision for the University of Chicago Medicine Comprehensive Cancer Center (UCCCC), and addresses Center’s overall goals, policies and operations. It serves as the framework for obtaining effective internal and external advice, setting priorities, making decisions and defining, evaluating and executing the Strategic Plan. Significant and substantial changes took place in Senior Leadership over the past funding period. Kunle Odunsi, MD, PhD, a well-regarded physician/scientist with immense Cancer Center experience, was recruited as Director of UCCCC in March 2021. Odunsi identified a new Deputy Director and 6 new Associate Directors (ADs), 2 of which are new AD positions: AD for Diversity, Equity and Inclusion and AD for Shared Resources. Senior Leadership sets the goals with guidance from the Executive Committee, program leaders, component leaders, community members, as well as internal and external advisory committees. During the current funding period, the Senior Leadership Team led a comprehensive strategic planning and evaluation effort. This resulted in a five-year Strategic Plan (2022-2027), that robustly aligns programmatic initiatives and organizational priorities for the Cancer Center. A formal External Advisory Committee (EAC) meets annualy, along with mini-EAC Retreats throughout the year addressing specific components of the CCSG, to provide objective evaluation and advice to the Director. The external advisors are appropriately balanced for basic laboratory, clinical, prevention, cancer control and population science and administrative expertise. UCCCC led seminars, retreats and workshops aim to stimulate transdisciplinary research opportunities and assessment of implementation of strategic goals. The aims of Leadership, Planning and Evaluation are: (1) To establish a leadership structure to support the UCCCC mission; (2) To engage in planning and development of a unified Strategic Plan and develop tactics to execute strategic decisions and oversee implementation of the Strategic Plan; (3) To track success, implement change, and evaluate performance of the UCCCC using external and internal advisory groups. Overall, Odunsi and the UCCCC Senior Leadership team have effectively utilized the Cancer Center Support Grant to put in place a vigorous and robust process of vision setting, evaluation of progress, implementation of improvements, and planning for the future.

View original record on NIH RePORTER →